Work

Randomized phase II trial of maintenance sunitinib versus placebo following response to chemotherapy (CT) for patients (pts) with advanced urothelial carcinoma (UC).

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.5_suppl.265

Authors: Petros Grivas, David M. Nanus, Walter Michael Stadler, Stephanie Daignault, Robert Dreicer, Manish Kohli, Daniel Peter Petrylak, David J. Vaughn, Kathryn A. Bylow, Arie S. Belldegrun, Joseph L. Sottnik, Evan T. Keller, David C. Smith, Maha Hussain

Institutions: Cleveland Clinic, Mayo Clinic, University of California, Los Angeles, Medical College of Wisconsin, University of Michigan, University of Chicago, Weill Cornell Medicine, Abramson Cancer Center, Columbia University

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2584536354

Cites:

Cited by: 10

Related to: 10